ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd.

HYFT · NASDAQ · Healthcare / Biotechnology

0.99USD-0.01 (-1.00%)

Price History

Full chart

Market Stats

Previous Close1.00
Open0.9987
Day Range0.9111 – 1.06
52-Week Range0.99 – 2.99
Volume349.28K
Market Cap65.01M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.26
Dividend Yield0.00%
Beta0.83
50-Day Avg1.36
200-Day Avg1.48

About

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Jennifer Lynne Bath Ph.D.
  • Employees74
  • HeadquartersIndustrious 823 Congress Ave, Austin, TX, United States, 78701, USA
  • Websitehttps://www.mindwalkai.com

Leadership

  • Dr. Jennifer Lynne Bath Ph.D.CEO, President & Non-Independent Director
  • Mr. Richard Scott AregladoChief Financial Officer · b. 1964
  • Dr. Thomas Lynch Ph.D.Chief Business Officer
  • Ms. Kari GraberVice President of Commercial Services
  • Dr. Shuji SatoVice President of Innovative Solutions
  • Mr. Dirk Van Hyfte M.D., Ph.D.Chief Technology Officer
  • Mr. Frederic ChabotHead of Corporate Development
  • Ms. Ingrid Brands M.D., Ph.D.Chief Innovation & Strategy Officer
  • Ms. Lori AndersonVice President of Brand Marketing and Creative

Financials

Income Statement

Currency: CAD1997-04-301998-04-301999-04-302000-04-302001-04-302002-04-302003-04-302004-04-302005-04-302006-04-302007-04-302008-04-302009-04-302010-04-302011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Revenue6.53K5852.73K7.58K330386------------1.76M1.90M2.63M5.44M10.93M14.72M17.91M19.36M20.66M24.52M24.52M15.32M
Growth (%)--99.11%+90815.52%-85.62%-95.65%+16.97%-------------+7.51%+38.73%+106.85%+100.80%+34.72%+21.69%+8.11%+6.72%+18.65%+0.01%-37.52%
Cost of Revenue---------7.45K7.45K3.64K2.81K3.27K2.68K2.25K1.26K1.40K1.04K823.061.21M2.99M5.63M15.30M6.37M8.38M9.10M12.46M10.97M6.31M
Gross Profit6.53K6052.73K7.58K330386----7.45K-7.45K-3.64K-2.81K-3.27K-2.68K-2.25K-1.26K-1.40K-1.04K-8231.42M2.45M5.29M-576.29K11.54M10.98M11.56M12.05M13.55M9.01M
Gross Margin100.00%103.45%100.00%100.00%100.00%100.00%-------------0.06%-0.04%54.01%45.04%48.46%-3.92%64.41%56.72%55.95%49.16%55.25%58.80%
Operating Expense228.13K370.20K1.30M1.24M148.91K233.22K---239.03K239.03K560.36K404.87K267.91K254.27K211.09K80.66K94.00K64.99K-243.47K2.81M7.38M11.52M3.71M15.71M27.66M37.17M25.82M25.74M23.72M
Operating Income-221.61K-370.14K-1.25M-1.23M-148.58K-232.84K-158.00K-642.00K-201.00K-246.48K-246.48K-564.00K-407.68K-271.17K-256.95K-213.34K-81.92K-95.39K-66.03K242.65K-1.39M-4.93M-6.23M-4.29M-4.18M-16.67M-25.61M-13.76M-12.20M-14.71M
Operating Margin-3396.29%-638170.69%-2370.32%-16219.33%-45024.55%-60320.73%-------------3.74%12.80%-52.71%-90.59%-56.97%-29.13%-23.31%-86.10%-123.93%-56.13%-49.74%-96.01%
EBITDA-218.50K-276.31K-177.31K-173.98K-147.73K-191.37K-156.00K26.87K-196.00K-407.92K-407.92K-997.24K-475.85K-1.27M-5.13M-280.61K-94.20K69.50K-61.08K293.83K-5.40M-4.35M-4.03M-1.24M-1.42M-11.99M-21.04M-22.95M-28.86M-13.13M
EBITDA Margin-3348.66%-476403.45%-336.25%-2293.75%-44767.88%-49576.42%-------------3.46%15.50%-205.26%-79.90%-36.89%-8.41%-7.92%-61.94%-101.80%-93.60%-117.68%-85.70%
Net Income-720.44K-763.97K-1.25M-1.25M-134.30K-235.41K-284.00K-565.00K-187.00K-415.37K-415.37K-692.99K-478.66K-912.03K-5.14M-283.13K-95.61K67.99K-62.46K151.03K-5.38M-5.17M-7.62M-5.18M-7.34M-16.71M-26.56M-26.11M-30.23M-13.74M
Net Income Margin-11041.18%-1317193.10%-2371.67%-16414.49%-40696.06%-60986.27%-------------3.54%7.97%-204.67%-95.03%-69.72%-35.19%-40.98%-86.29%-128.53%-106.51%-123.30%-89.66%
R&D------------------621.64K302.77K660.41K509.25K485.85K467.29K1.97M7.66M14.10M4.04M4.94M4.86M
R&D as % of Total Revenue------------------35.25%15.97%25.11%9.36%4.45%3.17%11.02%39.57%68.24%16.49%20.16%31.71%
Interest Expense----326--615-50.18K3.04K-39326.14K3.48K271.15148.75117.49338.82259.9116.77K84.22K858.32K736.27K602.37K85.00K30.00K19.00K9.91K0
Interest Expense % of Total Revenue----98.79%-------------0.02%0.01%0.64%1.55%7.86%5.00%3.36%0.44%0.15%0.08%0.04%0.00%

Balance Sheet

Currency: CAD1997-04-301998-04-301999-04-302000-04-302001-04-302002-04-302003-04-302004-04-302005-04-302006-04-302007-04-302008-04-302009-04-302010-04-302011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Assets3.88M2.93M1.66M406.64K1.16M879.28K928.23K1.44M4.28M4.05M5.56M5.16M6.93M5.47M211.00K93.22K49.97K142.29K46.12K1.38M3.93M24.58M28.35M27.26M66.96M93.49M77.81M59.99M44.44M21.34M
Total Liabilities250.04K67.39K35.78K10.11K896.75K187.72K16.02K49.92K47.18K138.62K155.85K37.46K150.84K100.47K85.19K213.10K265.63K303.50K254.64K472.15K836.91K11.87M10.28M12.18M10.04M18.36M20.01M26.07M20.82M9.61M
Total Equity3.63M2.86M1.62M396.53K262.24K691.56K912.21K1.39M4.23M3.91M5.40M5.12M6.78M5.37M125.81K-119.89K-215.66K-161.21K-208.52K908.26K3.09M12.70M18.07M15.09M56.92M75.28M57.80M33.92M23.63M11.73M
Cash358.35K883.07K407.95K94.19K78.55K26.75K51.94K534.11K2.54M29.87K99.53K199.44K318.95K60.53K55.67K18.59K14.26K40.56K3.85K340.88K2.58M1.81M5.47M2.61M41.76M29.96M8.28M3.46M10.66M11.33M
Total Debt------7.50K---------50.00K122.90K73.96K--3.82M2.93M4.51M4.26M2.77M14.27M13.68M13.40M3.52M
Net Debt-358.35K-883.07K-407.95K-94.19K-78.55K-26.75K-44.44K-534.11K-2.54M-29.87K-99.53K-199.44K-318.95K-60.53K-55.67K-18.59K35.74K82.34K70.11K-340.88K-2.58M2.01M-2.54M1.90M-37.50M-27.20M5.99M10.22M2.74M-7.81M

Cash Flow

Currency: CAD1997-04-301998-04-301999-04-302000-04-302001-04-302002-04-302003-04-302004-04-302005-04-302006-04-302007-04-302008-04-302009-04-302010-04-302011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow-108.20K-226.81K-202.94K-208.54K-8.13K-280.23K-168.38K-178.69K-82.20K-110.59K-297.31K-523.45K-155.68K-308.49K-80.39K-132.72K-4.33K-46.60K-36.11K284.09K-721.65K-3.42M-3.21M-1.39M-600.00K-9.92M-19.83M-4.25M-6.41M-12.27M
Investing Cash Flow-2.38M751.07K-273.70K-132.23K-732.24K130.44K-149.43K-243.14K-834.27K-1.85M-1.82M-34.59K-1.27M-232.99K54.90K18.24K---600-81.59K-174.61K-7.17M-2.20M-1.58M-2.46M-5.21M-1.97M-1.56M-799.00K13.34M
Financing Cash Flow1.27M4641.53K27.01K724.73K98.00K302.00K945.00K2.92M75.00K1.83M397.50K1.88M--50.00K-72.90K-600-91.91K3.17M9.80M9.35M174.70K43.38M2.88M-621.00K1.02M14.89M113.23K
Capital Expenditure519.92K1.08M367.18K154.24K700.39K8.88K149.43K256.50K859.77K1.85M1.82M105.04K1.39M322.81K13.65K1.64K0020.32K17.48K530.75K345.49K645.06K575.64K1.43M1.26M1.50M1.40M799.00K391.90K
Free Cash Flow-628.12K-1.31M-570.11K-362.77K-708.53K-289.12K-317.81K-435.20K-941.97K-1.96M-2.12M-628.49K-1.54M-631.30K-94.04K-134.35K-4.33K-46.60K-56.42K266.61K-1.25M-3.76M-3.85M-1.97M-2.03M-11.18M-21.33M-5.64M-7.21M-12.66M
Dividends Paid------------------200.00K65.00K90.00K---------
FCF to OCF580.50%575.95%280.93%173.96%8710.68%103.17%188.75%243.54%1145.93%1770.65%713.61%120.07%992.43%204.64%116.99%101.23%100.00%100.00%156.27%93.85%173.55%110.11%120.12%141.37%337.83%112.67%107.54%132.90%112.46%103.19%
Dividend Paid to FCF-------------------354.47%24.38%-7.19%---------

Earnings

Report DateJan 31, 2017Apr 30, 2017Jul 31, 2017Oct 31, 2017Jan 31, 2018Apr 30, 2018Oct 3, 2018Jan 2, 2019Apr 3, 2019Jul 3, 2019Oct 2, 2019Jan 1, 2020Apr 1, 2020Jul 1, 2020Sep 30, 2020Dec 30, 2020Mar 18, 2021Jul 28, 2021Sep 9, 2021Dec 13, 2021Mar 16, 2022Jul 29, 2022Sep 14, 2022Dec 15, 2022Mar 16, 2023Jul 7, 2023Sep 14, 2023Dec 14, 2023Mar 14, 2024Jul 29, 2024Sep 16, 2024Dec 10, 2024Mar 28, 2025Jul 29, 2025Sep 15, 2025Dec 15, 2025Mar 12, 2026Jul 22, 2026Sep 14, 2026
EPS Estimate------------------------0.14-0.12--0.15-0.10-0.07-0.08--0.07-0.06-0.04-0.04-0.01-0.04-0.05-0.05
EPS Actual-0.97-0.12-0.08-0.08-0.10-0.16-0.08-0.09-0.07-0.21-0.11-0.08-0.04-0.05-0.03-0.02-0.06-0.24-0.14-0.21-0.16-0.17-0.29-0.22-0.14-0.15-0.10-0.07-0.08-0.10-0.11-0.06-0.46-0.04-0.09-0.05-0.06-0.06-0.09
Surprise------------------------57.14%-16.67%-33.33%30.00%-14.29%-25.00%-14.29%-666.67%0.00%-109.30%-400.00%-50.00%-20.00%-80.00%
Timing-----------------------Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap65.01M
Enterprise Value66.78M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.01
Price / Book13.98
EPS-0.26
Book Value0.1057
Revenue (TTM)16.23M
Gross Profit (TTM)9.87M
EBITDA-16.10M
Profit Margin-105.20%
Operating Margin-159.86%
Return on Equity-123.66%
Return on Assets-36.39%
Shares Outstanding47.11M
Shares Float42.68M
Beta0.83
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
9.29%
Insiders
9.14%
Retail / Other
81.57%

Top Institutional Holders

  • Ingalls & Snyder LLC
    2.91M6.19%
  • Susquehanna International Group, LLP
    534.02K1.14%
  • Renaissance Technologies Corp
    232.48K0.49%
  • XTX Topco Ltd
    172.55K0.37%
  • Jane Street Group LLC
    126.55K0.27%
  • Bank of Montreal
    77.95K0.17%
  • BMO Capital Markets Corp.
    69.95K0.15%
  • Bridgeway Capital Management, LLC
    50.00K0.11%
  • Virtu Financial LLC
    48.93K0.10%
  • UBS Group AG
    42.33K0.09%
  • Allianz Asset Management AG
    35.00K0.07%
  • GSA Capital Partners LLP
    34.52K0.07%
  • Gradient Capital Advisors, LLC
    26.55K0.06%
  • Marshall Wace Asset Management Ltd
    25.25K0.05%
  • Federation des caisses Desjardins du Quebec
    23.27K0.05%
  • Geode Capital Management, LLC
    16.13K0.03%
  • Tradition Wealth Management LLC
    13.18K0.03%
  • HRT FINANCIAL LLC
    12.13K0.03%

Top Fund Holders

  • iShares Micro-Cap ETF
    143.77K0.31%
  • Fidelity Nasdaq Composite Index
    25.49K0.05%

Stock Splits

  • Nov 23, 20201:5
  • Sep 2, 20161:3
  • Sep 13, 20111:10